PRECLINICAL ALZHEIMER'S DISEASE
Clinical trials for PRECLINICAL ALZHEIMER'S DISEASE explained in plain language.
Never miss a new study
Get alerted when new PRECLINICAL ALZHEIMER'S DISEASE trials appear
Sign up with your email to follow new studies for PRECLINICAL ALZHEIMER'S DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New vaccine aims to halt Alzheimer's before symptoms start
Disease control OngoingThis study tests an experimental vaccine (JNJ-64042056) designed to help the immune system clear a harmful brain protein called tau. It includes 55 people with very early Alzheimer's signs but no memory problems. The goal is to see if the vaccine can slow tau buildup in the brain…
Matched conditions: PRECLINICAL ALZHEIMER'S DISEASE
Phase: PHASE2 • Sponsor: Janssen Pharmaceutica N.V., Belgium • Aim: Disease control
Last updated May 17, 2026 03:55 UTC
-
Can a new drug stop Alzheimer's before it starts? major trial underway
Disease control OngoingThis study tests whether the drug lecanemab can slow down memory loss and brain changes in people who have early signs of Alzheimer's but no symptoms yet. About 1,400 volunteers aged 55-80 with elevated brain amyloid will receive either lecanemab or a placebo for up to 4 years. T…
Matched conditions: PRECLINICAL ALZHEIMER'S DISEASE
Phase: PHASE3 • Sponsor: Eisai Inc. • Aim: Disease control
Last updated May 17, 2026 03:53 UTC